Cargando…
Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994662/ https://www.ncbi.nlm.nih.gov/pubmed/36910332 http://dx.doi.org/10.2147/NDT.S407852 |
_version_ | 1784902661293735936 |
---|---|
author | Wessa, Céline Morrens, Manuel De Picker, Livia J |
author_facet | Wessa, Céline Morrens, Manuel De Picker, Livia J |
author_sort | Wessa, Céline |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9994662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-99946622023-03-09 Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] Wessa, Céline Morrens, Manuel De Picker, Livia J Neuropsychiatr Dis Treat Letter Dove 2023-03-04 /pmc/articles/PMC9994662/ /pubmed/36910332 http://dx.doi.org/10.2147/NDT.S407852 Text en © 2023 Wessa et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Wessa, Céline Morrens, Manuel De Picker, Livia J Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] |
title | Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] |
title_full | Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] |
title_fullStr | Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] |
title_full_unstemmed | Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] |
title_short | Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter] |
title_sort | choice of outcome measure predicts anti-inflammatory treatment efficacy in major depressive disorder [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994662/ https://www.ncbi.nlm.nih.gov/pubmed/36910332 http://dx.doi.org/10.2147/NDT.S407852 |
work_keys_str_mv | AT wessaceline choiceofoutcomemeasurepredictsantiinflammatorytreatmentefficacyinmajordepressivedisorderletter AT morrensmanuel choiceofoutcomemeasurepredictsantiinflammatorytreatmentefficacyinmajordepressivedisorderletter AT depickerliviaj choiceofoutcomemeasurepredictsantiinflammatorytreatmentefficacyinmajordepressivedisorderletter |